PT3082865T - Prevenção e neutralização do risco de trombose induzida por dieta - Google Patents

Prevenção e neutralização do risco de trombose induzida por dieta

Info

Publication number
PT3082865T
PT3082865T PT148162712T PT14816271T PT3082865T PT 3082865 T PT3082865 T PT 3082865T PT 148162712 T PT148162712 T PT 148162712T PT 14816271 T PT14816271 T PT 14816271T PT 3082865 T PT3082865 T PT 3082865T
Authority
PT
Portugal
Prior art keywords
counteraction
diet
prevention
induced thrombosis
thrombosis risk
Prior art date
Application number
PT148162712T
Other languages
English (en)
Original Assignee
Nattopharma Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattopharma Asa filed Critical Nattopharma Asa
Publication of PT3082865T publication Critical patent/PT3082865T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT148162712T 2013-12-20 2014-12-19 Prevenção e neutralização do risco de trombose induzida por dieta PT3082865T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13198969.1A EP2886129A1 (en) 2013-12-20 2013-12-20 Prevention and counteraction of diet-induced thrombosis risk

Publications (1)

Publication Number Publication Date
PT3082865T true PT3082865T (pt) 2021-11-16

Family

ID=49882890

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148162712T PT3082865T (pt) 2013-12-20 2014-12-19 Prevenção e neutralização do risco de trombose induzida por dieta

Country Status (8)

Country Link
US (1) US20160310445A1 (pt)
EP (2) EP2886129A1 (pt)
DK (1) DK3082865T3 (pt)
ES (1) ES2896945T3 (pt)
HU (1) HUE056231T2 (pt)
PL (1) PL3082865T3 (pt)
PT (1) PT3082865T (pt)
WO (1) WO2015092018A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
AU2020236308B2 (en) * 2019-03-12 2024-10-10 Nattopharma As Use of vitamin K in combination with anticoagulants
WO2021206560A1 (en) * 2020-04-09 2021-10-14 Emphysema Solutions Bv Use of vitamin k in preventing or counteracting covid-19 disease and diagnostic test to estimate the risk of developing severe disease or mortality by covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
PL2046312T3 (pl) 2006-07-14 2021-02-08 Kaydence Pharma As Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2
BRPI0812686A2 (pt) * 2007-07-24 2011-10-18 Viridis Biopharma Pvt Ltd meios de aplicação de análogos da vitamina k e derivados para o tratamento de condições de doença humana e distúrbios
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2

Also Published As

Publication number Publication date
US20160310445A1 (en) 2016-10-27
DK3082865T3 (da) 2021-11-15
EP3082865B1 (en) 2021-08-11
EP2886129A1 (en) 2015-06-24
WO2015092018A1 (en) 2015-06-25
EP3082865A1 (en) 2016-10-26
PL3082865T3 (pl) 2021-12-27
ES2896945T3 (es) 2022-02-28
HUE056231T2 (hu) 2022-02-28

Similar Documents

Publication Publication Date Title
HK1217908A1 (zh) 治療膽管癌的方法
HK1223401A1 (zh) 用於治療遺傳病狀的方法和組合物
HK1218506A1 (zh) 治療黑素瘤的方法
EP2970317A4 (en) PYRIMIDODIAZEPINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF DISEASES
HK1224210A1 (zh) 用於治療纖維化的方法和組合物
IL282482A (en) Variants of protoxin-II and methods of use
HK1258349A1 (zh) Hppd變體及使用方法
IL282508A (en) Variants of protoxin-II and methods of use
HK1224307A1 (zh) 原毒素- 變體及其使用方法
EP3632467C0 (en) INHIBITORS OF COMPLEMENT FACTOR H
HK1222129A1 (zh) 脱氧野尻霉素衍生物及其使用方法
IL239909A0 (en) Methods for treating cardiovascular signs
HK1243961A1 (zh) 炎性病况的預防和治療
IL241096A0 (en) Treatment methods
PT3082865T (pt) Prevenção e neutralização do risco de trombose induzida por dieta
AP2015008645A0 (en) Methods of handling papaya
EP3077048A4 (en) Compositions and methods of treating thrombosis
HK1220396A1 (zh) 痤瘡的治療和預防
GB201309431D0 (en) Treatment and prevention of malaria
GB201309001D0 (en) Methods for prevention and treatment of preeclampsia
GB201306975D0 (en) Stents and methods of manufacture
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment